Oppenheimer Maintains an 'Outperform' on TPC Group (TPCG); Butadiene Contract Prices Fall
Tweet
Share
E-mailGet Alerts TPCG Hot Sheet
Price: $45.00 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on TPC Group (NASDAQ: TPCG) price target of $55.00.
Analyst, Edward Yang, said, "North America's contract price for butadiene (BD) in September settled at $0.843, down $0.068 or 7% from August's $0.911. The decline is consistent with a slow economy, and while it's not good to see slippage, we believe it has no long-term impact on TPCG and is not enough to disrupt contract renewal negotiations. No change to estimates."
For an analyst ratings summary and ratings history on TPC Group click here. For more ratings news on TPC Group click here.
Shares of TPC Group closed at $40.88 yesterday.
Analyst, Edward Yang, said, "North America's contract price for butadiene (BD) in September settled at $0.843, down $0.068 or 7% from August's $0.911. The decline is consistent with a slow economy, and while it's not good to see slippage, we believe it has no long-term impact on TPCG and is not enough to disrupt contract renewal negotiations. No change to estimates."
For an analyst ratings summary and ratings history on TPC Group click here. For more ratings news on TPC Group click here.
Shares of TPC Group closed at $40.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
